Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (111-120 of 601) with videos related to

Pageof 61
Sort By:
Stroke|September 5, 2015
Hyperglycemia and PPARγ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic StrokeMichael Gliem, Luisa Klotz, Nico van Rooijen, et al.
Drugs|September 15, 2017
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple SclerosisGiancarlo Comi, Hans-Peter Hartung, Rajesh Bakshi, et al.
Archives of Neurology|November 15, 2006
Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosisTea Kopadze, Thomas Dehmel, Hans-Peter Hartung, et al.
The International Journal of Neuropsychopharmacology|October 17, 2008
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokinesPatrick Vollmar, Stefan Nessler, Sudhakar Reddy Kalluri, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 6, 2012
Inflammatory demyelinating brain lesions heralding primary CNS lymphomaLeila Husseini, Andreas Saleh, Guido Reifenberger, et al.
Current Opinion in Neurology|April 16, 2019
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and changeHans-Peter Hartung, Jonas Graf, Orhan Aktas, et al.
Drug Design, Development and Therapy|August 7, 2010
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribineClemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al.
Microbiology (Reading, England)|April 17, 1999
Cloning, sequencing and molecular analysis of the Campylobacter jejuni groESL bicistronic operonFrank L Thies, Andreas Weishaupt, Helge Karch, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Fulminant intramedullary spinal cord sarcoidosisJonas Graf, Marius Ringelstein, Orhan Aktas, et al.
Archives of Neurology|June 14, 2006
Interleukin 23 in acute inflammatory demyelination of the peripheral nerveWei Hu, Thomas Dehmel, Jaana Pirhonen, et al.
Pageof 61

Showing results (111-120 of 601) with videos related to

Sort By:
Pageof 61
Stroke|September 5, 2015
Hyperglycemia and PPARγ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic StrokeMichael Gliem, Luisa Klotz, Nico van Rooijen, et al.
Drugs|September 15, 2017
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple SclerosisGiancarlo Comi, Hans-Peter Hartung, Rajesh Bakshi, et al.
Archives of Neurology|November 15, 2006
Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosisTea Kopadze, Thomas Dehmel, Hans-Peter Hartung, et al.
The International Journal of Neuropsychopharmacology|October 17, 2008
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokinesPatrick Vollmar, Stefan Nessler, Sudhakar Reddy Kalluri, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 6, 2012
Inflammatory demyelinating brain lesions heralding primary CNS lymphomaLeila Husseini, Andreas Saleh, Guido Reifenberger, et al.
Current Opinion in Neurology|April 16, 2019
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and changeHans-Peter Hartung, Jonas Graf, Orhan Aktas, et al.
Drug Design, Development and Therapy|August 7, 2010
Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribineClemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al.
Microbiology (Reading, England)|April 17, 1999
Cloning, sequencing and molecular analysis of the Campylobacter jejuni groESL bicistronic operonFrank L Thies, Andreas Weishaupt, Helge Karch, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Fulminant intramedullary spinal cord sarcoidosisJonas Graf, Marius Ringelstein, Orhan Aktas, et al.
Archives of Neurology|June 14, 2006
Interleukin 23 in acute inflammatory demyelination of the peripheral nerveWei Hu, Thomas Dehmel, Jaana Pirhonen, et al.
Pageof 61